BIIB

Biogen Inc.

224.00 USD
-2.61 (-1.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Biogen Inc. stock is up 2.41% since 30 days ago. The next earnings date is Jul 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 48.39% of the previous 30 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Jun 14:32 21 Jun, 2024 230.00 PUT 150 398
14 Jun 19:12 20 Jun, 2025 200.00 PUT 30 266
17 Jun 14:58 19 Jul, 2024 240.00 CALL 144 388
17 Jun 14:58 19 Jul, 2024 240.00 CALL 242 388
20 Jun 13:30 17 Jan, 2025 300.00 CALL 100 390
20 Jun 13:40 17 Jan, 2025 250.00 CALL 40 184
20 Jun 15:58 17 Jan, 2025 250.00 CALL 40 184
21 Jun 14:13 17 Jan, 2025 270.00 PUT 20 46
25 Jun 13:33 16 Aug, 2024 230.00 CALL 40 181
25 Jun 14:46 17 Jan, 2025 250.00 CALL 40 211

About Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis. It also offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and pemphigus vulgaris.

  • RBC Capital
    Wed Jun 5, 10:34
    buy
    confirm
  • RBC Capital
    Wed May 29, 09:58
    buy
    confirm